Search - tctmd.com

Displaying 1 - 20 of 609

Sort: Relevancy | Date

News Daily News

Multimodality Imaging May Better Stratify MACE Risk in Myocarditis

Caitlin E. Cox

September 28, 2026

News Daily News

Lp(a)HORIZON: Top-line Results Dash Hopes for Pelacarsen

Caitlin E. Cox

September 08, 2026

News Conference News ESC 2026

TRANQUILITY: Pacibekitug Safely Lowers hs-CRP Through 6 Months in CKD Patients

Caitlin E. Cox

September 04, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2026

Caitlin E. Cox

September 02, 2026

News Conference News ESC 2026

TARGET-CTCA: When MI’s Already Ruled Out in Chest Pain, Imaging Doesn’t Add Much

L.A. McKeown

August 31, 2026

News Daily News

Central Adiposity Gives Greater Insight Into CV Risk Than BMI

Caitlin E. Cox

August 12, 2026

News Daily News

Claims Data Lend Support to Tirzepatide’s CV Effects in Patients With Diabetes

Caitlin E. Cox

August 07, 2026

News Daily News

ZEUS Trial: Ziltivekimab Fails to Reduce MACE in ASCVD Patients

Caitlin E. Cox

August 03, 2026

News Conference News SCCT 2026

Quantifying Inflammation Can Add to CV Risk Prediction Even in No-Contrast Scans

Yael L. Maxwell

July 22, 2026

News Daily News

Lengthier DAPT Worthwhile in Some MVD Patients Post-PCI

Caitlin E. Cox

July 17, 2026

News Daily News

What’s in a Name? Researchers Push for MINOCA Rethink

L.A. McKeown

July 10, 2026

In industrialized countries, the gaps in systolic BP and cholesterol have shrunk between obese and normal-weight individuals.

News Daily News

BMI Appears to Carry Less Weight as Medical Therapy Improves

Caitlin E. Cox

July 10, 2026

News Daily News

GLP-1 Use May Benefit Autoimmune Disease Patients With Obesity

L.A. McKeown

June 12, 2026

News Daily News

Semaglutide Benefits Diabetic Patients Regardless of CVD Status: FLOW Subanalysis

L.A. McKeown

June 02, 2026

News Conference News ESC Heart Failure 2026

Inflammation Common in HF, No Matter the Ejection Fraction: POSEIDON

Caitlin E. Cox

May 18, 2026

News Conference News HRS 2026

GLP-1s May Prevent Incident AF, Series of Studies Shows

Todd Neale

April 30, 2026

News Daily News

GLP-1 Drugs May Lower CV Risk in TAVI Patients With Diabetes or Obesity

Yael L. Maxwell

April 29, 2026

News Conference News ACC 2026

SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF

Todd Neale

March 29, 2026

News Daily News

Genomics, Lipids, Inflammation at Midlife Predict Future CAD

Caitlin E. Cox

March 25, 2026

Advertisement

Multimodality Imaging May Better Stratify MACE Risk in Myocarditis

Lp(a)HORIZON: Top-line Results Dash Hopes for Pelacarsen

TRANQUILITY: Pacibekitug Safely Lowers hs-CRP Through 6 Months in CKD Patients

TCTMD’s Top 10 Most Popular Stories for August 2026

TARGET-CTCA: When MI’s Already Ruled Out in Chest Pain, Imaging Doesn’t Add Much

Central Adiposity Gives Greater Insight Into CV Risk Than BMI

Claims Data Lend Support to Tirzepatide’s CV Effects in Patients With Diabetes

ZEUS Trial: Ziltivekimab Fails to Reduce MACE in ASCVD Patients

Quantifying Inflammation Can Add to CV Risk Prediction Even in No-Contrast Scans

Lengthier DAPT Worthwhile in Some MVD Patients Post-PCI

What’s in a Name? Researchers Push for MINOCA Rethink

BMI Appears to Carry Less Weight as Medical Therapy Improves

GLP-1 Use May Benefit Autoimmune Disease Patients With Obesity

Semaglutide Benefits Diabetic Patients Regardless of CVD Status: FLOW Subanalysis

Inflammation Common in HF, No Matter the Ejection Fraction: POSEIDON

GLP-1s May Prevent Incident AF, Series of Studies Shows

GLP-1 Drugs May Lower CV Risk in TAVI Patients With Diabetes or Obesity

SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF

Genomics, Lipids, Inflammation at Midlife Predict Future CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content